Pancracine
Pancracine is an alkaloid. Pancracine upregulates p27, phosphorylated p38 MAPK and phosphorylated p53, while downregulating phosphorylated Akt and phosphorylated Rb. Pancracine induces G1 cell cycle arrest and Apoptosis in cells. Pancracine inhibits the replication of pseudotyped HIV-1 and Dengue virus. Pancracine can be used in research related to lung adenocarcinoma, acute lymphoblastic leukemia, cutaneous epidermoid carcinoma, human immunodeficiency virus infection and dengue virus infection.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 21416-14-8
- Formel: C16H17NO4
- Molecular Weight:287.31
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[2]|
HIV-1 |
In Vitro
Pancracine (1-50 μM; up to 96 h) inhibits the proliferation of A549, MCF-7, HepG2 and A2780 cells in a concentration-dependent manner, and 20 μM Pancracine completely arrests the proliferation of A549 cells for up to 96 h[1].
Pancracine (2.5-20 μM; 24-72 h (A549); 24-48 h (MOLT-4)) exerts significant antiproliferative effects on A549 and MOLT-4 cells at concentrations ≥2.5 μM, and MOLT-4 cells are more sensitive to Pancracine-induced viability loss than A549 cells[1].
Pancracine (0.5-10 μM; 24 h) exhibits selective cytotoxicity against the epidermoid cancer cell line A431[2].
Pancracine (0.05-200 μM) exhibits cytotoxicity against THP-1 acute monocytic leukemia cells, with a CC50 value of 25.93 μM[2].
Pancracine (2.5-20 μM; 24-48 h) induces G1 phase arrest in A549 cells at 5 μM for 24 h, and shifts to G2 phase arrest at 20 μM for 48 h; meanwhile, it reduces the proportion of S phase cells at higher concentrations and with longer incubation times[1].
Pancracine (10-20 μM; 24-72 h) inhibits the proliferation of A549 cells by regulating the Akt/p27/pRb and p38 MAPK/ERK signaling pathways; when the concentration is ≥10 μM and the treatment lasts for 72 h, increased phosphorylation level of p38 MAPK, decreased phosphorylation levels of ERK and pRb, as well as increased p27 level and decreased phosphorylation level of Akt are observed[1].
Pancracine (2.5-10 μM; 24-48 h) induces G1 phase arrest and increases the sub-G1 apoptotic cell population in MOLT-4 cells. Significant G1 phase shift is observed at 2.5 μM after 24 h and at 5 μM after 48 h, and the sub-G1 apoptotic cells increase in a dose-dependent manner[1].
Pancracine (5-20 μM) significantly increases the activities of caspase-3/7, -8, and -9 in MOLT-4 cells at concentrations ≥10 μM after 24 h of treatment, but does not induce caspase activation in A549 cells[1].
Pancracine (2.5-20 μM; 24 h) induces dose-dependent apoptosis in MOLT-4 cells after 24 hours, with the total proportion of apoptotic cells reaching 48% (14% early apoptosis and 34% late apoptosis) following treatment with 20 μM Pancracine[1].
Pancracine (0.5-200 μM; 72 h) potently inhibits infection by pseudotyped HIV-1GFP in THP-1 acute monocytic leukemia cells, with an EC50 of 18.51 μM, and achieves complete inhibition at a concentration of 100 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human A549 lung adenocarcinoma, MCF-7 breast adenocarcinoma, HepG2 hepatocellular carcinoma, A2780 ovarian carcinoma cells
-
Concentration:1, 5, 10, 20, 50 μM
-
Incubation Time:up to 96 h
-
Result:Reduced proliferation in all tested cell lines in a concentration-dependent manner.
Halted proliferation entirely in A549 cells over the 96-h assay interval at 20 μM.
Significantly reduced A549 cell proliferation at 5 and 10 μM.
-
Cell Line:human A549 lung adenocarcinoma, MOLT-4 acute lymphoblastic leukemia cells
-
Concentration:2.5, 5, 10, 20 μM
-
Incubation Time:24-72 h (A549); 24-48 h (MOLT-4)
-
Result:Exerted significant antiproliferative effect on A549 cells at 2.5 μM after 48 and 72 h, with increasing effects at higher concentrations.
Caused slight decrease in A549 cell viability only at 10 and 20 μM.
Exerted significant antiproliferative effect on MOLT-4 cells at 2.5 μM after 24 and 48 h.
Reduced MOLT-4 viability significantly at 5 μM after 48 h and at 10 μM after 24 h.
Reduced MOLT-4 viability to ~20% at 20 μM.
-
Cell Line:human A549 lung adenocarcinoma cells
-
Concentration:2.5-20 μM (24 h); 20 μM (48 h)
-
Incubation Time:24-48 h
-
Result:Caused significant increase in A549 cells in G1 phase at 5 μM after 24 h.
Caused significant increase in G1 and G2 phase cells, with concurrent decrease in S phase cells at 20 μM after 24 h.
Caused significant increase in G2 phase cells, with reduction in G1 and S phase cells at 20 μM after 48 h.
-
Cell Line:human MOLT-4 acute lymphoblastic leukemia cells
-
Concentration:2.5, 5, 10, 20 μM
-
Incubation Time:24 h
-
Result:Resulted in early apoptotic rates of 3%, 4%, 10%, and 14% at 2.5, 5, 10, and 20 μM respectively after 24 h.
Resulted in late apoptotic rates of 2%, 3%, 14%, and 34% at 2.5, 5, 10, and 20 μM respectively after 24 h.
Resulted in 48% total apoptotic cells (14% early, 34% late) at 20 μM after 24 h.
Chemical Information
-
CAS. Nr. 21416-14-8
-
Molecular Weight 287.31
-
Formel C16H17NO4
-
SMILES
O[C@H]1C=C2[C@]3([H])C4=CC(OCO5)=C5C=C4C[N@]([C@@]2([H])C[C@@H]1O)C3
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
Reinheit & Dokumentation
Verweise
[1]. Koutová D, et al. Pancracine, a Montanine-Type Amaryllidaceae Alkaloid, Inhibits Proliferation of A549 Lung Adenocarcinoma Cells and Induces Apoptotic Cell Death in MOLT-4 Leukemic Cells. International journal of molecular sciences. 2021 Jun 29;22(13):7014. [Content Brief]
[2]. Masi M, et al. Cytotoxicity and Antiviral Properties of Alkaloids Isolated from Pancratium maritimum. Toxins (Basel). 2022 Apr 7;14(4):262. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)